Stocks and Investing Stocks and Investing
Thu, January 7, 2021
[ 12:00 AM ] - WOPRAI
Laurence Alexander Upgraded (AVNT) to Strong Buy and Increased Target to $56 on, Jan 7th, 2021
[ 12:00 AM ] - WOPRAI
C. Gregory Peters Maintained (ALL) at Strong Buy with Increased Target to $125 on, Jan 7th, 2021
[ 12:00 AM ] - WOPRAI
Jim Kelleher Maintained (AMAT) at Strong Buy with Increased Target to $110 on, Jan 7th, 2021
[ 12:00 AM ] - WOPRAI
Mehdi Hosseini Maintained (AMAT) at Buy with Increased Target to $106 on, Jan 7th, 2021
[ 12:00 AM ] - WOPRAI
David Larsen Initiated (ACCD) at Strong Buy and Held Target at $55 on, Jan 7th, 2021
[ 12:00 AM ] - WOPRAI
Karen Short Downgraded (ACI) to Sell and Held Target at $17 on, Jan 7th, 2021
[ 12:00 AM ] - WOPRAI
Seth Sigman Downgraded (SPWH) to Hold and Held Target at $18 on, Jan 7th, 2021
[ 12:00 AM ] - WOPRAI
Karen Short Downgraded (SPTN) to Sell and Held Target at $18 on, Jan 7th, 2021
[ 12:00 AM ] - WOPRAI
Robert Driscoll Initiated (BDTX) at Buy on, Jan 7th, 2021
[ 12:00 AM ] - WOPRAI
Prashant Rao Maintained (VLO) at Strong Buy with Increased Target to $70 on, Jan 7th, 2021
[ 12:00 AM ] - WOPRAI
Ken Zerbe Maintained (VLY) at Hold with Increased Target to $12 on, Jan 7th, 2021
[ 12:00 AM ] - WOPRAI
Christopher Growe Downgraded (SMPL) to Hold and Held Target at $30 on, Jan 7th, 2021
[ 12:00 AM ] - WOPRAI
Leo Mariani Maintained (SM) at Buy with Increased Target to $8 on, Jan 7th, 2021
[ 12:00 AM ] - WOPRAI
Casey Haire Upgraded (SNV) to Strong Buy and Increased Target to $40 on, Jan 7th, 2021
[ 12:00 AM ] - WOPRAI
Michael Rose Maintained (SNV) at Buy with Increased Target to $40 on, Jan 7th, 2021
[ 12:00 AM ] - WOPRAI
Ken Zerbe Maintained (SNV) at Buy with Increased Target to $42 on, Jan 7th, 2021
[ 12:00 AM ] - WOPRAI
Ken Zerbe Maintained (CBSH) at Sell with Increased Target to $52 on, Jan 7th, 2021
[ 12:00 AM ] - WOPRAI
Kenneth Worthington Downgraded (CBOE) to Sell on, Jan 7th, 2021
[ 12:00 AM ] - WOPRAI
Ken Zerbe Maintained (CADE) at Hold with Increased Target to $19 on, Jan 7th, 2021
[ 12:00 AM ] - WOPRAI
James Rutherford Upgraded (CAKE) to Hold and Increased Target to $36 on, Jan 7th, 2021
[ 12:00 AM ] - WOPRAI
Ken Zerbe Maintained (BKU) at Hold with Increased Target to $40 on, Jan 7th, 2021
[ 12:00 AM ] - WOPRAI
James Rutherford Upgraded (BJRI) to Buy and Increased Target to $46 on, Jan 7th, 2021
[ 12:00 AM ] - WOPRAI
Ken Zerbe Maintained (CFR) at Sell with Increased Target to $81 on, Jan 7th, 2021
[ 12:00 AM ] - WOPRAI
Joseph Spak Upgraded (TSLA) to Hold and Increased Target to $233 on, Jan 7th, 2021
[ 12:00 AM ] - WOPRAI
Michael Rose Maintained (VBTX) at Strong Buy with Increased Target to $33 on, Jan 7th, 2021
[ 12:00 AM ] - WOPRAI
Donald Hooker Initiated (VEEV) at Buy and Held Target at $332 on, Jan 7th, 2021
[ 12:00 AM ] - WOPRAI
Ken Usdin Upgraded (USB) to Strong Buy on, Jan 7th, 2021
[ 12:00 AM ] - WOPRAI
Erika Najarian Downgraded (USB) to Sell and Increased Target to $52 on, Jan 7th, 2021
[ 12:00 AM ] - WOPRAI
Matthew Boss Maintained (VFC) at Buy with Increased Target to $100 on, Jan 7th, 2021
Wed, January 6, 2021
[ 12:00 AM ] - WOPRAI
Geulah Livshits Initiated (VINC) at Strong Buy and Held Target at $33 on, Jan 6th, 2021

Geulah Livshits Initiated (VINC) at Strong Buy and Held Target at $33 on, Jan 6th, 2021


Published on 2024-10-27 15:07:51 - WOPRAI, Geulah Livshits
  Print publication without navigation


Geulah Livshits of Chardan Capital, Initiated "Vincerx Pharma, Inc." (VINC) at Strong Buy and Held Target at $33 on, Jan 6th, 2021.

Geulah, nor any peers, have made any analyst calls on VINC in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources